Literature DB >> 25277040

Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.

Gero Lueg1, Catharina C Gross1, Hubertus Lohmann1, Andreas Johnen1, Andre Kemmling2, Michael Deppe1, Julia Groger1, Jens Minnerup1, Heinz Wiendl1, Sven G Meuth1, Thomas Duning3.   

Abstract

In Alzheimer's disease, the contribution of inflammation is still controversially discussed. The aim of this study was to identify a particular immune profile in the peripheral blood (PB) and cerebrospinal fluid (CSF) in patients with mild Alzheimer's disease (mAD) and mild cognitive impairment (MCI) and its potential functional relevance and association with neurodegeneration. A total of 88 patients with cognitive decline (54 mAD, 19 MCI, and 15 other dementias) were included in this study and compared with a group of younger (mean age, 31.3 years) and older (mean age, 68.9 years) healthy volunteers. Patients underwent detailed neurologic and neuropsychological examination, magnetic resonance imaging including voxel-based morphometry of gray matter, voxel-based diffusion tensor imaging, and white matter lesion volumetry, and PB and CSF analysis including multiparameter flow cytometry. Multiparameter flow cytometry revealed that proportions of activated HLA-DR positive CD4(+) and CD8(+) T-cells were slightly and significantly increased in the PB of MCI and mAD patients, respectively, when compared with healthy elderly controls but not in patients with other dementias. Although only a slight enhancement of the proportion of activated CD4(+) T-cells was observed in the CSF of both MCI and mAD patients, the proportion of activated CD8(+) T-cells was significantly increased in the CSF of mAD patients when compared with healthy elderly individuals. A slight increase in the proportion of activated CD8(+) T-cells was also observed in the intrathecal compartment of MCI patients. Activation of cytotoxic CD8(+) T-cells was considerably related to AD-typical neuropsychological deficits. Voxel-based regression analysis revealed a significant correlation between CD8(+) T-cell activation and microstructural tissue damage within parahippocampal areas as assessed by diffusion tensor imaging. Taken together, peripheral and intrathecal CD8(+) T-cell activation in mAD was significantly different from other dementias, suggesting a specific adaptive immune response. Lymphocyte activation seems to have a clinical impact because levels of activated CD8(+) T-cells were correlated with clinical and structural markers of AD pathology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  All cognitive disorders; Alzheimer's disease; CSF; Cerebrospinal fluid; Dementia; Neuroinflammation; PB; Peripheral blood; T-cells

Mesh:

Substances:

Year:  2014        PMID: 25277040     DOI: 10.1016/j.neurobiolaging.2014.08.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  53 in total

Review 1.  Human T cell immunosenescence and inflammation in aging.

Authors:  Arsun Bektas; Shepherd H Schurman; Ranjan Sen; Luigi Ferrucci
Journal:  J Leukoc Biol       Date:  2017-07-21       Impact factor: 4.962

2.  Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.

Authors:  Junling Yang; Jinghong Kou; Robert Lalonde; Ken-Ichiro Fukuchi
Journal:  Brain Behav Immun       Date:  2017-05-17       Impact factor: 7.217

3.  Women's Pregnancy Life History and Alzheimer's Risk: Can Immunoregulation Explain the Link?

Authors:  Molly Fox; Carlo Berzuini; Leslie A Knapp; Laura M Glynn
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-07-30       Impact factor: 2.035

Review 4.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

5.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 6.  Central Nervous System: (Immunological) Ivory Tower or Not?

Authors:  Ioana A Marin; Jonathan Kipnis
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

Review 7.  [Cytology of cerebrospinal fluid : Standards, importance and modern methods].

Authors:  M Wick; C C Gross; S Isenmann; H Strik
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

Review 8.  Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges?

Authors:  Stefan Prokop; Virginia M Y Lee; John Q Trojanowski
Journal:  Prog Mol Biol Transl Sci       Date:  2019-10-24       Impact factor: 3.622

9.  An immune-cell signature marks the brain in Alzheimer's disease.

Authors:  Michael T Heneka
Journal:  Nature       Date:  2020-01       Impact factor: 49.962

Review 10.  T cell responses in the central nervous system.

Authors:  Thomas Korn; Axel Kallies
Journal:  Nat Rev Immunol       Date:  2017-01-31       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.